Australia invests $8 M for research into neurofibromatosis

The Australian Government is investing $8 million to support the Children’s Tumour Foundation and research into ne...

February 11, 2021 | Thursday | News
Olympus supports dissemination of endoscopic procedures for Colorectal Cancer in Russia

Olympus Corporation announced on Feb 4, 2021 that it has been selected by Japan's Ministry of Health, Labour and Welfare...

February 9, 2021 | Tuesday | News
Japan invests in development program for skin microbiome

MyBiotics Pharma, a microbiome therapeutics company based in Israel, announced that it has received an investment from&n...

February 8, 2021 | Monday | News
Thermo Fisher, JW Therapeutics announce CAR-T partnership in China

Thermo Fisher Scientific has signed an agreement with JW Therapeutics, a leading cell therapy company, to ensure non-exc...

February 4, 2021 | Thursday | News
Singapore provides important clinical implications for COVID-19 management

Antibodies and T cells are components of the human immune system that directly act against viral infections and eliminat...

February 2, 2021 | Tuesday | News
Singapore designs tool to investigate hospital borne bacterial infections

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...

January 28, 2021 | Thursday | News
Singapore designs armoured anti-cancer T cells against immunosuppressants

Duke-NUS Medical School researchers, together with collaborators in Singapore, have designed armoured immune cells that ...

January 19, 2021 | Tuesday | News
TenNor, Janssen plan new treatments for non-tuberculous mycobacteria diseases

TenNor Therapeutics (Suzhou) Limited, a clinical-stage biopharmaceutical company dedicated to research and development o...

January 19, 2021 | Tuesday | News
Singapore finds new mechanism of cancer formation

A team of scientists at the National University of Singapore (NUS) led by Dr Polly Leilei Chen from the C...

January 15, 2021 | Friday | News
PharmAbcine Inc collaborates with LegoChem for R&D of ADCs

PharmAbcine Inc, a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, ...

January 12, 2021 | Tuesday | News
Australia puts $38 M for research into diabetes, heart disease

Two new medical research centres will be funded by the Australian government to produce rapid improvements in preventing...

January 12, 2021 | Tuesday | News
Australia reports new defence against mosquito-borne viruses

A team of researchers at Australia's The University of Queensland, School of Chemistry and Molecular Biosciences ha...

January 11, 2021 | Monday | News
Merck acquires AmpTec expanding mRNA capabilities for vaccines and diagnostics

Merck, a leading science and technology company, on Jan 7, 2021 announced the acquisition of Am...

January 8, 2021 | Friday | News
India identifies genetic link for heart disease & diabetes among South Asians

Heart failure is a leading cause of death worldwide, shown to increasingly affect young individuals below the age of 40....

January 8, 2021 | Friday | News
Singapore launches spin-off to develop treatment for intractable diseases

The Experimental Drug Development Centre (EDDC), a national platform for drug discovery and development hosted by A*STAR...

December 24, 2020 | Thursday | News
Alterity, UniQuest team up to reverse bacterial resistance to antibiotics

Alterity Therapeutics has announced it has been granted a licence by UniQuest, the commercialisation company of The ...

December 22, 2020 | Tuesday | News
Harbour BioMed licenses SARS-CoV-2 neutralizing Ab to AbbVie for COVID-19 treatment

China based Harbour BioMed and Utrecht University in the Netherlands have announced that they licensed to American firm ...

December 22, 2020 | Tuesday | News
Sosei Heptares and GSK target immune disorders of digestive system

Japanese firm Sosei Group Corporation has announced that it has entered into a global collaboration and license agr...

December 21, 2020 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls